Tarsons Products Limited (TARSONS) — Financial Results
Tarsons Products Limited reported consolidated revenue of ₹422.5 crores for FY26, reflecting an 8% YoY growth, driven by domestic demand and new capacity utilization, though PAT declined due to depreciation and finance costs from new facilities. Exports fell 13% in Q4FY26 amid Middle East geopolitical disruptions, while adjusted cash PAT grew 21% YoY to ₹112 crores. The company emphasized full commissioning of Panchla and Amta facilities by H1FY27 to accelerate growth.
About Tarsons Products Limited (TARSONS)
Healthcare · Healthcare Equipment & Supplies · Listed on NSE
📡 Get AI alerts when TARSONS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track TARSONS — Free💡 Ask AI about this filing
📊 More TARSONS filings
- share transfer — 9 July 2026 Tarsons Products Limited received a SEBI Regulation 74(5) certificate from its share transfer agent ...
- Financial Results — 23 June 2026 Tarsons Products Limited announced that its trading window will close on July 1, 2026, for all desig...
- Announcement — 18 June 2026 Tarsons Products Limited clarified that recent price movement is market-driven with no undisclosed m...
- Announcement — 16 June 2026 No summary available
- 🟡 Board Meeting — 15 June 2026 No summary available
🔥 Also filed on 23 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when TARSONS files new disclosures
Track TARSONS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track TARSONS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research